| Serial Number | 98370905 |
| Word Mark | MYOPEPDYS (VESLETEPLIRSEN) INJECTION |
| Filing Date | Tuesday, January 23, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, August 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 1, 2024 |
| Goods and Services | Medical training and teaching |
| Description of Mark | The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical services; providing health information |
| NOT AVAILABLE | "VESLETEPLIRSEN INJECTION" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, January 23, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 19, 2024 | ASSIGNED TO EXAMINER |
| Friday, August 23, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 23, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 23, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 23, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 28, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |